FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945206329> ?p ?o ?g. }

• W2945206329 endingPage "921" @default.
• W2945206329 startingPage "921" @default.
• W2945206329 abstract "This study looked into the synthesis and study of Dextrane Sulfate-Doxorubicin Nanoparticles (DS-Dox NP) that are sensitive to amylase and show anticoagulant properties. The particles were obtained by the method of solvent replacement. They had a size of 305 ± 58 nm, with a mass ratio of DS:Dox = 3.3:1. On heating to 37 °C, the release of Dox from the particles was equal to 24.2% of the drug contained. In the presence of amylase, this ratio had increased to 42.1%. The study of the biological activity of the particles included an assessment of the cytotoxicity and the effect on hemostasis and antitumor activity. In a study of cytotoxicity on the L929 cell culture, it was found that the synthesized particles had less toxicity, compared to free doxorubicin. However, in the presence of amylase, their cytotoxicity was higher than the traditional forms of the drug. In a study of the effect of DS-Dox NP on hemostasis, it was found that the particles had a heparin-like anticoagulant effect. Antitumor activity was studied on the model of ascitic Zaidel hepatoma in rats. The frequency of complete cure in animals treated with the DS-Dox nanoparticles was higher, compared to animals receiving the traditional form of the drug." @default.
• W2945206329 created "2019-05-29" @default.
• W2945206329 creator A5010918381 @default.
• W2945206329 creator A5018140229 @default.
• W2945206329 creator A5024208674 @default.
• W2945206329 creator A5026735966 @default.
• W2945206329 creator A5041541239 @default.
• W2945206329 creator A5053368430 @default.
• W2945206329 creator A5061746177 @default.
• W2945206329 creator A5066482952 @default.
• W2945206329 creator A5067887053 @default.
• W2945206329 creator A5069164099 @default.
• W2945206329 creator A5084674462 @default.
• W2945206329 date "2019-05-25" @default.
• W2945206329 modified "2023-10-16" @default.
• W2945206329 title "Amylase-Sensitive Polymeric Nanoparticles Based on Dextran Sulfate and Doxorubicin with Anticoagulant Activity" @default.
• W2945206329 cites W131842592 @default.
• W2945206329 cites W1505366254 @default.
• W2945206329 cites W153688333 @default.
• W2945206329 cites W1560614145 @default.
• W2945206329 cites W1897953391 @default.
• W2945206329 cites W1963806455 @default.
• W2945206329 cites W1967523014 @default.
• W2945206329 cites W1969313893 @default.
• W2945206329 cites W1976371089 @default.
• W2945206329 cites W1984095308 @default.
• W2945206329 cites W1991410755 @default.
• W2945206329 cites W1996706046 @default.
• W2945206329 cites W1998271063 @default.
• W2945206329 cites W2000958679 @default.
• W2945206329 cites W2002392659 @default.
• W2945206329 cites W2010228388 @default.
• W2945206329 cites W2018505095 @default.
• W2945206329 cites W2018926498 @default.
• W2945206329 cites W2020153557 @default.
• W2945206329 cites W2044523186 @default.
• W2945206329 cites W2050978321 @default.
• W2945206329 cites W2057283407 @default.
• W2945206329 cites W2064258113 @default.
• W2945206329 cites W2074789769 @default.
• W2945206329 cites W2075264956 @default.
• W2945206329 cites W2076274584 @default.
• W2945206329 cites W2081938664 @default.
• W2945206329 cites W2087414776 @default.
• W2945206329 cites W2105672544 @default.
• W2945206329 cites W2119973415 @default.
• W2945206329 cites W2126876006 @default.
• W2945206329 cites W2165210975 @default.
• W2945206329 cites W2183370948 @default.
• W2945206329 cites W2234954424 @default.
• W2945206329 cites W2279413142 @default.
• W2945206329 cites W2296308400 @default.
• W2945206329 cites W2314127735 @default.
• W2945206329 cites W2582346419 @default.
• W2945206329 cites W2605303992 @default.
• W2945206329 cites W2761903020 @default.
• W2945206329 cites W2765996276 @default.
• W2945206329 cites W2769106804 @default.
• W2945206329 cites W2794165335 @default.
• W2945206329 cites W2796938019 @default.
• W2945206329 cites W2896607810 @default.
• W2945206329 cites W2900475493 @default.
• W2945206329 cites W2988009715 @default.
• W2945206329 cites W39614084 @default.
• W2945206329 cites W4244875684 @default.
• W2945206329 cites W4380994635 @default.
• W2945206329 doi "https://doi.org/10.3390/polym11050921" @default.
• W2945206329 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6571953" @default.
• W2945206329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31130638" @default.
• W2945206329 hasPublicationYear "2019" @default.
• W2945206329 type Work @default.
• W2945206329 sameAs 2945206329 @default.
• W2945206329 citedByCount "6" @default.
• W2945206329 countsByYear W29452063292020 @default.
• W2945206329 countsByYear W29452063292021 @default.
• W2945206329 countsByYear W29452063292022 @default.
• W2945206329 countsByYear W29452063292023 @default.
• W2945206329 crossrefType "journal-article" @default.
• W2945206329 hasAuthorship W2945206329A5010918381 @default.
• W2945206329 hasAuthorship W2945206329A5018140229 @default.
• W2945206329 hasAuthorship W2945206329A5024208674 @default.
• W2945206329 hasAuthorship W2945206329A5026735966 @default.
• W2945206329 hasAuthorship W2945206329A5041541239 @default.
• W2945206329 hasAuthorship W2945206329A5053368430 @default.
• W2945206329 hasAuthorship W2945206329A5061746177 @default.
• W2945206329 hasAuthorship W2945206329A5066482952 @default.
• W2945206329 hasAuthorship W2945206329A5067887053 @default.
• W2945206329 hasAuthorship W2945206329A5069164099 @default.
• W2945206329 hasAuthorship W2945206329A5084674462 @default.
• W2945206329 hasBestOaLocation W29452063291 @default.
• W2945206329 hasConcept C109316439 @default.
• W2945206329 hasConcept C126322002 @default.
• W2945206329 hasConcept C155672457 @default.
• W2945206329 hasConcept C170835558 @default.
• W2945206329 hasConcept C171250308 @default.
• W2945206329 hasConcept C181199279 @default.
• W2945206329 hasConcept C185592680 @default.
• W2945206329 hasConcept C192562407 @default.

• next